No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment

Lignende værker

• No Mortality Difference Following Treatment with Terlipressin or Somatostatin in Cirrhotic Patients with Gastric Variceal Hemorrhage
  af: Hung, Tsung-Hsing, et al.
  Udgivet: (2016)
• A fourfold increase of oesophageal variceal bleeding in cirrhotic patients with a history of oesophageal variceal bleeding
  af: Hung, Tsung-Hsing, et al.
  Udgivet: (2016)
• Terlipressin or somatostatin for the treatment of bleeding oesophageal varices
  af: Boyd, R., et al.
  Udgivet: (2005)
• High mortality of pneumonia in cirrhotic patients with ascites
  af: Hung, Tsung-Hsing, et al.
  Udgivet: (2013)
• The long-term outcomes of cirrhotic patients with pleural effusion
  af: Hung, Tsung-Hsing, et al.
  Udgivet: (2018)